Literature DB >> 1956050

Gossypol and derivatives: a new class of aldose reductase inhibitors.

L M Deck1, D L Vander Jagt, R E Royer.   

Abstract

Gossypol and 17 derivatives were tested as inhibitors of aldose reductase from human placenta. Gossypol and a number of the derivatives were potent inhibitors. The order of inhibitory activity was interpreted in relation to the Kador-Sharpless pharmacophor model for the aldose reductase inhibitor site. The structural but not the electronic aspects of the model were found to apply to this series of compounds.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1956050     DOI: 10.1021/jm00115a021

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  5 in total

Review 1.  Small-molecule inhibitors of human LDH5.

Authors:  Carlotta Granchi; Ilaria Paterni; Reshma Rani; Filippo Minutolo
Journal:  Future Med Chem       Date:  2013-10       Impact factor: 3.808

2.  Synthesis of benzyl substituted naphthalenes from benzylidene tetralones.

Authors:  Lorraine M Deck; Quintino Mgani; Andrea Martinez; Alice Martinic; Lisa J Whalen; David L Vander Jagt; Robert E Royer
Journal:  Tetrahedron Lett       Date:  2012-01-25       Impact factor: 2.415

3.  Gossypol with Hydrophobic Linear Esters Exhibits Enhanced Antitumor Activity as an Inhibitor of Antiapoptotic Proteins.

Authors:  Yuzhi Lu; Shuangchan Wu; Yuan Yue; Si He; Jun Li; Jun Tang; Wei Wang; Hai-Bing Zhou
Journal:  ACS Med Chem Lett       Date:  2016-10-19       Impact factor: 4.345

4.  Practical Strategy to 1,1'-Dideoxygossypol Derivatives from Gossypol and Its Antitumor Activities.

Authors:  Wei Wang; Yuzhi Lu; Juncheng Ge; Niya Liu
Journal:  ACS Omega       Date:  2022-06-22

5.  Synthesis of Hemigossypol and its Derivatives.

Authors:  Jun Wei; David L Vander Jagt; Robert E Royer; Lorraine M Deck
Journal:  Tetrahedron Lett       Date:  2010-08-30       Impact factor: 2.415

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.